MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

AtriCure Inc

Închisă

SectorSănătate

39.5 -1.72

Rezumat

Modificarea prețului

24h

Curent

Minim

39.35

Maxim

40.09

Indicatori cheie

By Trading Economics

Venit

5.9M

-267K

Vânzări

-1.9M

134M

Marjă de profit

-0.199

Angajați

1,300

EBITDA

7.3M

8M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+28.99% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

144M

2B

Deschiderea anterioară

41.22

Închiderea anterioară

39.5

Sentimentul știrilor

By Acuity

55%

45%

310 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

AtriCure Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 dec. 2025, 22:20 UTC

Principalele dinamici ale pieței

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec. 2025, 17:31 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec. 2025, 16:30 UTC

Principalele dinamici ale pieței

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec. 2025, 15:19 UTC

Principalele dinamici ale pieței

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec. 2025, 15:17 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec. 2025, 14:37 UTC

Principalele dinamici ale pieței

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 dec. 2025, 21:13 UTC

Achiziții, Fuziuni, Preluări

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec. 2025, 17:16 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 dec. 2025, 17:00 UTC

Achiziții, Fuziuni, Preluări

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec. 2025, 15:57 UTC

Achiziții, Fuziuni, Preluări

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec. 2025, 15:02 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec. 2025, 14:40 UTC

Achiziții, Fuziuni, Preluări

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 dec. 2025, 13:01 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 dec. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 dec. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 dec. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 dec. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 dec. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparație

Modificare preț

AtriCure Inc Așteptări

Obiectiv de preț

By TipRanks

28.99% sus

Prognoză pe 12 luni

Medie 51.83 USD  28.99%

Maxim 64 USD

Minim 45 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAtriCure Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

6

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

30.36 / 33.4Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

310 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
help-icon Live chat